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Background: The root bark of Paeonia suffruticosa Andrews (PSE), also known as Moutan Cortex, has been widely
used in Asia to treat various diseases. The molecular mechanisms by which PSE exerts its anti-oxidant and anti-
inflammatory activities are well known, but its anti-cancer activity is not yet well understood. Here, we present
evidence demonstrating that PSE can be used as a potent anti-cancer agent to treat gastric cancer.
Methods: The effects of the ethanol extract of PSE on cell proliferation were determined using an MTT (1-(4,5-
dimethylthiazol-2-yl)-3,5-diphenylformazan) assay. Cell cytotoxicity induced by the PSE extact is measured using an
LDH leakage assay. Flow cytometry was used to analyze the cell cycle and to measure the subG0/G1 apoptotic cell
fraction. Apoptosis induced by the PSE extact is also examined using a DNA fragmentation assay. Western blot
analysis is used to measure the levels of apoptotic proteins such as Fas receptor, caspase-8, caspase-3, PARP, Bax,
Bcl-2, MDM2, and p53.
Results: This study demonstrated that treating AGS cells with the PSE extact significantly inhibited cell proliferation
and induced cytotoxicity in a dose- and time-dependent manner. The PSE extract also induced apoptosis in AGS
cells, as measured by flow cytometry and a DNA fragmentation assay. We found that the PSE extract induced
apoptosis via the extrinsic Fas-mediated apoptosis pathway, which was concurrent with the activation of caspases,
including caspase-8 and caspase-3, and cleavage of PARP. The MDM2-p53 pathway also played a role in the
apoptosis of AGS cells that was induced by the PSE extract.
Conclusions: These results clearly demonstrate that the PSE extact displays growth-suppressive activity and induces
apoptosis in AGS cells. Our data suggest that the PSE extact might be a potential anti-cancer agent for gastric
cancer.
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Apoptosis, or programmed cell death, occurs under
physiological and pharmacological stress in eukaryotic
cells [1-4]. The hallmarks of apoptotic cell death include
cell shrinkage, membrane blebbing, nuclear fragmenta-
tion, and chromatin condensation. These apoptotic
changes are due to the proteolytic activity of the caspase
proteases [5-7]. Apoptosis is mediated by either extrinsic
or intrinsic pathways, and both pathways converge on
the activation of effector caspases by initiator caspases.
In the extrinsic apoptosis pathway, Fas (also called Apo-
1 or CD95) is activated when the cell-surface death
receptors are upregulated, and activated Fas can then ac-
tivate the initiator caspases. The effector caspases are
directly cleaved and activated by initiator caspases,
resulting in the cleavage, degradation, or activation of
other cellular proteins. In the intrinsic apoptosis path-
way, mitochondrial outer membrane permeabilization
(MOMP) is changed, and the B cell lymphoma 2 (Bcl-2)
family plays a central role in cell death regulation. This
process leads to the release of pro-apoptotic proteins
from the mitochondrial intermembrane space (IMS) [5].
Worldwide, gastric cancer is the second leading cause of
cancer-related deaths, with only lung cancer ranking
higher [8,9]. The incidence of gastric cancer is high in
Eastern Asia, including Korea and Japan, as well as in
Eastern Europe, and South America. In contrast, the inci-
dence of gastric cancer is low in North America, Oceania,
Northern Europe, Southeast Asia, and Southern Asia [10].
A course of chemotherapy has been shown to be effective
in treating gastric cancer, but therapy-associated side
effects have also been reported [11]. Although various
advances have arisen in gastric cancer management, pa-
tient prognosis remains very poor [12]. Therefore, it is es-
sential to find new agents that can be used to enhance the
anti-cancer effects of common chemotherapeutic drugs
currently being used for gastric cancer treatment [11,12].
Although traditional medicine has been used for thou-
sands of years [13], the molecular mechanisms under-
lying the effects of these natural products obtained from
the extracts of medicinal plants is still unclear [14-16].
Identification of the biologically active compound is also
important in traditional medicine [17].
Moutan Cortex, the root bark of Paeonia suffruticosa
Andrews (PSE), belongs to the Paeoniaceae family [18].
PSE has been widely used in Asia to treat atheroscler-
osis, infection, inflammation, and cutaneous disease [19].
PSE has been shown to possess potent anti-oxidant,
anti-mutagenic, anti-proliferative, anti-invasive [20],
anti-arrhythmic [21], anti-inflammation [22], anti-
diabetic [23,24], and anti-obesity activities [25]. However,
the molecular mechanisms by which PSE exerts its anti-
cancer activity are not well understood. In the present
study, we investigated whether PSE displays growthsuppressive activity and induces apoptosis in AGS cells.
Here, we provide evidence that PSE can be used as a po-
tent anti-cancer agent to treat gastric cancer.
Methods
Reagents
RPMI 1640, FBS (fetal bovine serum), trypsin-EDTA, and
Dulbecco’s phosphate-buffered saline (D-PBS) were pur-
chased from Welgene (Daegu, Korea). The antibiotic-
antimycotic used was purchased from Gibco (Grand Is-
land, NY, USA). MTT (1-(4,5-dimethylthiazol-2-yl)-3,5-
diphenylformazan; Thiazolyl blue formazan), RNase A,
chloroform, potassium acetate, and p53 inhibitor (Pifi-
thrin-α) were purchased from Sigma-Aldrich (St. Louis,
MO, USA). An LDH leakage (CytoTox 96W Non-
Radioactive Cytotoxicity) assay kit was purchased from
Promega (Madison, WI, USA). The pan-caspase inhibitor
(z-VAD-fmk) was obtained from Calbiochem-Novabiochem
(La Jolla, CA, USA). Caspase-8 inhibitor (Z-IETD-fmk)
and caspase-9 inhibitor (Z-LEHD-fmk) were obtained
from R&D systems, Inc (Minneapolis, MN, USA). An EZ-
western chemiluminescent detection kit was purchased
from Daeillab service co. (Seoul, Korea). Cisplatin was
obtained from Ildong Pharmaceutical Co., Ltd (Seoul,
Korea).
Antibodies
Fas receptor, procaspase-3, cleaved caspases (−3 and −8),
and poly (ADP-ribose) polymerase (PARP) antibodies
were purchased from Cell Signaling Technology, Inc
(Danvers, MA, USA). Pro- and cleaved caspase-9, Bcl-2,
Bax and α-actin antibodies were purchased from Santa
Cruz Biotechnology (Santa Cruz, CA, USA). Mouse and
rabbit secondary antibodies were from Calbiochem-
Novabiochem (La Jolla, CA, USA). Goat secondary anti-
body was obtained from Jackson ImmunoResearch
(West Grove, PA, USA).
Preparation of Paeonia suffruticosa Andrews (PSE) extract
The bark of roots obtained from Paeonia suffruticosa
Andrews (PSE) used in this research was purchased from
Omniherb (Gyeong Buk, Korea). The roots of PSE (100 g)
were immersed twice in 1 L of 80% ethanol and then soni-
cated using an ultra-sonicator (Branson, USA) for 30 min
at room temperature. The resulting extract was then fil-
tered through a 0.22 mm filter and concentrated to ap-
proximately 100 mL under reducing pressure. The ethanol
extracts were dried in a 42°C water bath with the use of a
vacuum pump evaporator (Eyela, Japan) and then freeze-
dried for 72 h by freeze dryer (Matsushita, Japan). The
concentrated extract was then lyophilized, resulting in
20.5 g of powder that was subsequently dissolved in
DMSO to prepare a stock solution of 200 mg/mL. The
stock solution was stored at −80°C until use.
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AGS (human gastric cancer) cells were generously pro-
vided by Dr. H. P. Kim (Seoul National Cancer Institute,
Seoul, Korea) and maintained as a monolayer culture in
RPMI 1640 medium that was supplemented with 10%
FBS and 1% antibiotic-antimycotic at 37°C in a humidi-
fied incubator under 5% CO2 gas.
MTT assay
Inhibition of cell proliferation was determined using a
MTT assay. Briefly, AGS cells were seeded in a 96 multi-
well plate (5x103 cells / 100 μl), and incubated at 37°C.
The next day, the cells were treated with the PSE extract
(0, 0.01, 0.05, 0.1, 0.25 and 0.5 mg/ml) for 48 or 72 h.
After incubation, MTT reagents (0.5 mg/ml) were added
to each well, and the plates were incubated in the dark
at 37°C for 2 h. The medium was removed, formazan
was dissolved in DMSO, and the optical density was
measured at 570 nm using an ELISA plate reader. The
absorbance correlates with the viability of cells; there-
fore, the number of cells (% of control) was calculated
using the following formula: cell number (% of control) =
((absorbance of cells treated with herb extract) / (ab-
sorbance of control cells)) × 100. The control was AGS
cells without herb extract treatment.
LDH leakage assay
Cell cytotoxicity was determined by a LDH leakage
assay. Briefly, AGS cells were seeded in a 24 multi-well
plate (1.5x104 cells / ml), and incubated at 37°C. The
next day, the cells were treated with the PSE extract (0,
0.01, 0.05, 0.1, 0.25 and 0.5 mg/ml) for 48 or 72 h. After
incubation, the supernatant was transferred to EP tubes
and then centrifuged at 11,000 rpm for 5 min at 4°C.Figure 1 Effects of PSE on cell viability in AGS gastric cancer cells. Ce
treatment with multiple concentrations of PSE and DMSO (48 h and 72 h).
corresponds to 100%. The data shown are representative of three indepen
**p< 0.01, ***p< 0.001, control versus PSE-treated cells.The supernatant was then transferred to new EP tubes.
Next, 50 μl of the supernatant was pipetted into 96
multi-well plates, and the supernatant was mixed with
50 μl of CytoTox 96W Non-Radioactive Cytotoxicity
assay reagents. After 30 min of incubation in the dark at
room temperature, 50 μl of stop solution was added to
each well. The absorption values were measured at
492 nm using an ELISA plate reader. The absorbance
correlates to the viability of cells; therefore, the number
of cells (% of control) was calculated using the following
formula: cell number (% of control) = (absorbance of
cells treated with herb extract) / (absorbance of control
cells) × 100. The control was AGS cells without herb ex-
tract treatment.
Cell proliferation assay
Cells were seeded in 12-well culture plates at a density
of 5 × 104 cells/well. The next day, cells were treated
with caspase-8 inhibitor or caspase-9 inhibitor in the
presence or absence of PSE for 3 days. Cells were har-
vested by trypsinization, resuspended in 1–2 ml of
medium, and counted using a hemocytometer.
Cell cycle or DNA content analysis by flow cytometry
Cells were seeded in 60 mm dishes (2.5x105 cells/3 ml)
and incubated at 37°C. The next day, 200 μg/ml of PSE
was directly added to the culture media and incubated
for an additional 12, 24, or 36 h. After incubation, the
cells were washed with ice-cold PBS, trypsinized, col-
lected in a 15 ml conical tube, and pelleted by centrifu-
gation (1000 xg) for 5 min at 4°C. The pellets were
washed twice with ice-cold PBS, fixed in 70% ethanol,
washed in PBS, resuspended in 300 μl of PBS containing
50 μg/ml propidium iodide (PI) and 50 μg/ml RNase All viability was measured using an MTT assay in AGS cells after
Cell viability under basal conditions (i.e. no PSE and no DMSO)
dent experiments that gave similar results. Bars, SD. * p< 0.05,
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temperature. The DNA content in each cell nucleus was
determined with a FACSCalibur flow cytometer (Becton-
Dickinson, San Jose, CA, USA), and the cell cycle was
analyzed using ModFit LT V2.0 software.DNA fragmentation assay
Cells (6x105 cells/6 ml) were lysed in 500 μl of 0.3 M
Tris–HCl (pH 7.5) buffer containing 0.1 M NaCl,
0.01 M EDTA, and 0.2 M sucrose. After vortexing
briefly, 25 μl of 10% SDS was added to the samples, and
the samples were incubated for 30 min at 37°C. Next,
120 μl of 5 M KOAC (potassium acetate) was added to
the samples, and the samples were kept on ice for 1 h.
After centrifugation for 10 min at 4°C (at 15,000 rpm for
pellet formation), the pellets were removed. The super-
natant was treated with 500 μl of TE buffer (10 mM
Tris–HCl and 1 mM EDTA, pH 8.0) containing 2 μl of
RNase A (10 mg/ml) and was incubated for 30 min at
room temperature. An equal volume of phenol/chloro-
form/isoamyl alcohol (25/24/1; Usb) was added to the
supernatant. The supernatant was vortexed gently and
centrifuged for 30 min at 4°C (at 15,000 rpm). The
supernatant was removed and 400 μl of 100% EtOH and
80 μl of 3 M NaOAC were added to the pellets. The pel-
lets were mixed gently and incubated at −20°C for
30 min. After centrifugation for 30 min at 4°C (at
15,000 rpm), the supernatants were removed. Next, the
pellets were washed twice with 500 μl of 70% EtOH and
were centrifuged for 30 min at 4°C (at 15,000 rpm).
After removal of the supernatant, the pellets were dried
and dissolved in 10 μl of TE buffer. The DNA was
loaded on a 1.2% agarose gel.Figure 2 Effects of PSE on cell cytotoxicity in AGS gastric cancer cells
after treatment with multiple concentrations of PSE and DMSO (48 h and 7
DMSO) corresponds to 100 %. The data shown are representative of three
***p< 0.001, control versus PSE-treated cells.Western blot analysis
Harvested cells were lysed with buffer containing
20 mM Tris–HCl (pH 7.5), 150 mM NaCl, 1 mM EDTA,
1 mM Na2EDTA, 1 mM EGTA, 1% NP-40, 1% sodium
deoxycholate, 1 mM Na3VO4, 1 mM DTT, 1 mM NaF,
1 mM PMSF, and PI cocktail on ice for 30 min. The
lysates were cleared by centrifugation at 13,000 rpm for
20 min at 4°C. The supernatant was stored at −70°C
until use. The protein concentration was quantified
using a Bio-Rad Bradford protein assay (Bio-Rad,
Hercules, CA, USA). Next, total proteins (15–20 μg)
were electrophoresed using 6-15% reducing SDS-
polyacrylamide gels and transferred to nitrocellulose
membranes. After blocking with 0.1% Tween-20 in PBS
(PBST) containing 1% skim milk and 1% BSA for 1 h,
the membranes were incubated overnight at 4°C with
the indicated primary antibodies. After washing in 1X
PBST for 15 min (3 times x 5 min), the membranes were
incubated with diluted enzyme-linked secondary anti-
bodies. After washing in 1X PBST for 1 h (4 times x
15 min), the protein bands were detected using the EZ-
western chemiluminescent detection kit and visualized
by exposing the membranes to X-ray films. For the stud-
ies of caspase-dependent apoptosis, AGS cells were pre-
treated with z-VAD-fmk (50 μM) for 1 h before treat-
ment with PSE.Statistical analysis
All experiments were expressed as the means ± standard
deviations (SD) of at least three separate tests. Student’s
t-test was used for single variable comparisons, and a p-
value < 0.05 was considered statistically significant.. Cell cytotoxicity was measured by a LDH leakage assay in AGS cells
2 h). Cell cytotoxicity under basal conditions (i.e. no PSE and no
independent experiments that gave similar results. Bars, SD.
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The PSE extract inhibits cell proliferation in AGS cells
To investigate whether the PSE extract inhibits AGS
cell growth, the cells were treated with various concen-
trations (0–500 μg/ml) of the PSE extract for 48 and
72 h, and the viability was measured by a MTT assay.
Interestingly, the PSE extract inhibited cell growth in
both a dose- and a time-dependent manner (Figure 1).
Compared with the control cells, the IC50 values of
the PSE extract were approximately 220 and 200 μg/
ml at 48 and 72 h, respectively. These data suggest
that the PSE extract has a clear anti-proliferative effect
on AGS cells.Figure 3 PSE induced apoptosis, apoptotic body formation, and DNA
exposed to 200 μg/ml PSE and 0.1% DMSO for 12 h, 24 h, and 36 h. The D
percentage of sub-G1 phase cells was determined based on a DNA conten
DMSO for 12 h, 24 h, and 36 h. The percentage of morphologically change
were exposed to 200 μg/ml PSE, 0.1% DMSO and 40 μM cisplatin for 24 h.
electrophoresis. (D) AGS cells were exposed to 200 μg/ml PSE, 0.1% DMSO
using light microscopy (x200). The data shown are representative of three
**p < 0.01, ***p < 0.001, control versus PSE-treated cells.The PSE extract induces cell cytotoxicity in AGS cells
To examine the potential cell cytotoxic effects of the PSE
extract in AGS cells, the cells were treated with various
concentrations (0–500 μg/ml) of the PSE extract for 48
and 72 h, and the cytotoxicity was measured using Cyto-
Tox 96W Non-Radioactive Cytotoxicity assay reagents. We
found that PSE killed cells in both a dose- and a time-
dependent manner (Figure 2). Compared with the control
cells, the LC50 values of the PSE extract were approxi-
mately 140 and 190 μg/ml at 48 and 72 h, respectively.
These results strongly suggest that the anti-proliferative
effect of the PSE extract is caused by apoptotic cell death
because the PSE extract killed the AGS cells.fragmentation in AGS gastric cancer cells. (A) AGS cells were
NA content was analyzed using a FACStar flow cytometer, and the
t histogram. (B) AGS cells were exposed to 200 μg/ml PSE and 0.1%
d cells was determined based on a FSC/SSC dotplot. (C) AGS cells
DNA fragmentation was analyzed using a 1.2% agarose gel for
and 40 μM cisplatin for 24 h. The morphology of cells was imaged
independent experiments that gave similar results. Bars, SD. *p < 0.05,
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formation, and DNA fragmentation in AGS cells
To further study the cytotoxic effects of the PSE extract
in AGS cells, we treated cells with 200 μg/ml of the PSE
extract for 12–36 h and then analyzed the cells for sub-
G1 DNA contents using flow cytometry. At this concen-
tration, the PSE extract increased the sub-G1 apoptotic
fractions from 3.81% (12 h) to 18.75% (36 h) in a time-
dependent manner. In contrast, neither the untreated
control cells nor the DMSO treated cells showed any
significant changes in the sub-G1 apoptotic fraction
(from 0.68% (12 h) to 0.17% (36 h) and from 0.65%
(12 h) to 0.34% (36 h), respectively) (Figure 3A).Figure 4 Fas, caspase-8 and caspase-3-dependent apoptosis is induce
200 μg/ml PSE and 0.1% DMSO for 12 h and 24 h. The cell lysates were sep
specific antibodies was performed (anti-Fas receptor, anti-cleaved caspase-8
band intensities were normalized to α-actin. (C) AGS cells were exposed to
(50□M). The morphology of the cells was imaged using light microscopy
either with or without z-VAD-fmk (50□M) for 12 h, the cell lysates were se
specific antibodies was performed (anti-procaspase-3, anti-cleaved caspase-
data shown are representative of three independent experiments that gave
treated cells.Morphological analysis demonstrated that AGS cells
were divided into either a distinct subpopulation (FSC<
150) or the main population of cells (FSC 150–440)
after treatment with the PSE extract (Figure 3B). There
was a time-dependent increase in the FSC < 150 popula-
tion, from 2.47% (12 h) to 13.42% (36 h), after treatment
with 200 μg/ml of the PSE extract. In contrast, we did
not observe any statistically significant changes in con-
trol cells and DMSO treated cells.
A DNA fragmentation ladder showed that the PSE ex-
tract and cisplatin (positive control) induced apoptotic
DNA ladder formation (Figure 3C). Furthermore, the
PSE extract decreased monolayer cell growth andd by PSE in AGS gastric cancer cells. (A) AGS cells were exposed to
arated by SDS-PAGE gel electrophoresis, and Western blotting with
, anti-cleaved caspase-3, anti-cleaved-PARP, and anti-α-actin). (B) The
200 μg/ml PSE and 0.1% DMSO either with or without z-VAD-fmk
(x200). (D) AGS cells were exposed to 200 μg/ml PSE and 0.1% DMSO
parated by SDS-PAGE gel electrophoresis, and Western blotting with
8, anti-cleaved caspase-3, anti-cleaved-PARP, and anti-α-actin). The
similar results. Bars, SD. **p < 0.01, ***p < 0.001, control versus PSE-
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showed similar cellular changes. These results confirmed
that the PSE extract inhibits the proliferation of AGS
cells by inducing apoptosis.
The PSE extract induces apoptosis via the extrinsic Fas-,
caspase-8-, and caspase-3-dependent apoptosis pathway
in AGS gastric cancer cells
We investigated whether the PSE extract induces the ex-
trinsic apoptosis pathway in AGS cells. To address this
question, we measured the expression of death receptor
signaling-related proteins including Fas, caspase-8, cas-
pase-3, and PARP. We found that the PSE extract acti-
vated the Fas death receptor and cleaved caspase-8,
caspase-3, and PARP, as seen in Figure 4A and 4B.
When we used z-VAD-fmk (pan-caspase inhibitor), we
found that the growth inhibition induced by the PSE ex-
tract was abrogated (Figure 4C). Moreover, the cleavagesFigure 5 PSE does not induce the intrinsic apoptosis pathway in AGS
and 0.1% DMSO for 12 h and 24 h. The cell lysates were separated by SDS-
was performed (anti-procaspase-9, anti-cleaved caspase-9, anti-cleaved-Bax
2/Bax ratio of the band density was performed. (C) AGS cells were treated
and stained with 4 μg/ml JC-1. The data shown are representative of threeof caspase-8, caspase-3, and PARP were inhibited by z-
VAD-fmk, while the PSE extract alone still led to
the degradation of caspase-8, caspase-3, and PARP
(Figure 4D).Collectively, these results suggest that the
apoptotic cell death that is induced by the PSE extract in
AGS cells occurs via the caspase-dependent extrinsic
apoptosis pathway.
The PSE extract does not induce apoptosis through the
intrinsic mitochondrial apoptosis pathway in AGS cells
Next, we conducted an experiment to determine
whether the PSE extract induces the intrinsic mitochon-
drial apoptosis pathway in AGS cells. We measured the
expression of mitochondrial apoptosis pathway-related
proteins such as the anti-apoptotic protein Bcl-2 and the
pro-apoptotic protein Bax. As seen in Figure 5A and 5B,
the expression of Bcl-2 and Bax was not changed by the
PSE extract. Moreover, the mitochondrial apoptosisgastric cancer cells. (A) AGS cells were exposed to 200 μg/ml PSE
PAGE gel electrophoresis and Western blotting with specific antibodies
, anti-cleaved-Bcl-2, and anti-α-actin). (B) The quantification of the Bcl-
with 200 μg/ml PSE and 0.1% DMSO for 24 h, washed twice with PBS
independent experiments that gave similar results.
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the PSE extract (Figure 5A).
To confirm the western blot data, we measured the loss
of mitochondrial membrane potential (ΔΨm) using JC-1.
JC-1 shows a high mitochondrial ΔΨm with intense red
fluorescence, forming J-aggregates when the cells are in a
healthy non-apoptotic state. In apoptotic or unhealthy
cells (especially mitochondria-mediated apoptotic cells),
JC-1 shows green fluorescence, forming J-monomers that
have a low ΔΨm. The data in Figure 5C demonstrate that
the PSE extract did not affect mitochondria membrane
potential, as seen by the maintenance of red fluorescence
from 100% (control) to 100% (DMSO 0.1%) to 99.91%
(PSE). We suggest that the PSE extract does not induce
intrinsic mitochondrial apoptosis in AGS cells but induce
extrinsic death receptor related apoptosis.
To confirm whether the apoptosis induced by the PSE
extract is only via extrinsic Fas-, caspase-8-, and
caspase-3- dependent pathway, we treated AGS cells
with caspase-8 inhibitor (Z-IETD-fmk) and caspase-9 in-
hibitor (Z-LEHD-fmk) and performed proliferation assay
and western blot. We found that caspase-9 inhibitor
alone decreased weakly cell proliferation suggesting that
caspase-9 is not key enzyme to induce apoptosis
(Figure 6A). We also found that the PSE extract strongly
suppressed the cell proliferation even in the presence ofFigure 6 Effect of caspase-8 inhibitor and caspase-9 inhibitor on the
were seeded in 12-well culture plates at a density of 5 × 104 cells/well. The
caspase-9 inhibitor (40□M) in the presence or absence of 200 μg/ml PSE f
2 ml of medium, and counted using a hemocytometer. Bars, SD. *p < 0.05,
DMSO either with or without caspase-8 inhibitor (40□M) and caspase-9 in
gel electrophoresis, and Western blotting with specific antibodies was perf
PARP, and anti-Tubulin). The data shown are representative of three indepecaspase-8 inhibitor and caspase-9 inhibitor (Figure 6A).
Western blot data demonstrated that cleavages of cas-
pase-8, caspase-3, and PARP were inhibited by caspase-8
inhibitor and caspase-9 inhibitor (Figure 6B). These
results confirm that the apoptotic cell death that is
induced by the PSE extract in AGS cells occurs via the
caspase-dependent extrinsic apoptosis pathway.p53-dependent apoptosis is induced by the PSE extract in
AGS cells
We investigated whether the p53 protein, which plays an
important role in the induction of apoptosis, is regulated
by the PSE extract in AGS cells. We found that the PSE
extract significantly increased the expression of the ac-
tive form of p53 (phospho-p53), as seen in Figure 7A
and 7B. Interestingly, the expression of the active form
of MDM2 (phospho-MDM2), a negative regulator of
p53, was decreased. To confirm that p53 is implicated in
the apoptosis induced by the PSE extract, we treated
AGS cells with p53 inhibitor (Pifithrin-α) and performed
western blot. We found that cleavages of caspase-8, cas-
pase-3, and PARP were inhibited by p53 inhibitor
(Figure 7C). These data suggest that the PSE extract
induces apoptosis via the MDM2-p53-dependent path-
way in AGS cells.apoptosis induced by PSE in AGS gastric cancer cells. (A) AGS Cells
next day, cells were treated with caspase-8 inhibitor (40□M) or
or 3 days. Cells were harvested by trypsinization, resuspended in 1–
***p < 0.001. (B) AGS cells were exposed to 200 μg/ml PSE and 0.1%
hibitor (40□M) for 24 h, the cell lysates were separated by SDS-PAGE
ormed (anti-cleaved caspase-8, anti-cleaved caspase-3, anti-cleaved-
ndent experiments that gave similar results.
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Although the incidence of gastric cancer has declined
worldwide, the death rate continues to rise in Eastern
Asian countries [25,26]. In this study, we found that the
PSE extract effectively inhibits gastric cancer cell growth
via the extrinsic Fas-dependent apoptosis pathway.
Our results demonstrated that the PSE extract sup-
pressed cell growth and induced AGS cell cytotoxicity in
a dose- and time-dependent manner. The flow cytome-
try cell cycle analysis showed that the PSE extract
increased the sub-G1 apoptotic fraction from 3.81% to
18.75%.
In addition, morphological analysis demonstrated that
there was a time-dependent increase in the FSC < 150
population from 2.47% (12 h) to 13.42% (36 h) after
treatment with the PSE extract. In addition, the cells
treated with either the PSE extract or cisplatin showed
morphological changes in the cellular monolayer,Figure 7 p53-dependent apoptosis is induced by PSE in AGS gastric c
DMSO for 12 h and 24 h. The cell lysates were separated by SDS-PAGE gel
performed (anti-p53, anti-phospho-p53, anti-phospho-MDM2, and anti-α-ac
*p < 0.05, **p < 0.01, ***p < 0.001, control versus PSE-treated cells. (C) AGS c
with or without p53 inhibitor (Pifithrin-α, 20 μM). The cell lysates were sepa
specific antibodies was performed (anti-phospho-p53, anti-cleaved caspase
data shown are representative of three independent experiments that gaveincluding cell shrinkage and membrane blebs, as
revealed by microscopic studies [27]. Cisplatin (cis-dia-
mminedichloroplatinum(II)) is an anti-cancer agent that
is currently used to treat patients with a wide variety of
solid tumors, and it acts via a direct interaction with
DNA to form DNA adducts [9,28-30]. Cisplatin is
known to increase DNA fragmentation, so it was used as
a positive control for our study. DNA fragmentation was
observed in both the PSE extract - and cisplatin- treated
AGS cells, confirming the induction of apoptosis.
Our western blot analyses suggest that the PSE extract
induces apoptosis through the activation of the caspase
cascade. The present study revealed that treatment with
the PSE extract increased Fas receptor expression. Fas
(FasL), a cell surface molecule that belongs to the tumor
necrosis factor family, binds to its receptor Fas, which
leads to apoptosis in Fas-bearing cells [31]. Up-regulated
Fas receptor can lead to cleaved caspase-8, caspase-3,ancer cells. (A) AGS cells were exposed to 200 μg/ml PSE and 0.1%
electrophoresis, and Western blotting with specific antibodies was
tin). (B) The band intensities were normalized to α-actin. Bars, SD.
ells were exposed to 200 μg/ml PSE and 0.1% DMSO for 24 h either
rated by SDS-PAGE gel electrophoresis, and Western blotting with
-8, anti-cleaved caspase-3, anti-cleaved-PARP, and anti-Tubulin). The
similar results.
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signaling in AGS cells treated with the PSE extract. To
determine whether the apoptotic process was occurring
in a caspase-dependent manner, we pre-treated AGS
cells with z-VED-fmk, which is a known pan-caspase in-
hibitor. We found that the growth inhibition induced by
the PSE extract was abrogated by z-VAD-fmk, and the
cleavages of caspase-8, caspase-3, and PARP were inhib-
ited by z-VAD-fmk. Therefore, our data demonstrate
that the apoptotic process induced by the PSE extract is
caspase-dependent. Moreover, we found that caspase-8
inhibitor or caspase-9 inhibitor alone did not strongly
affect apoptosis in AGS cells. This event may explain
that apoptosis needs the complex action of caspases and
caspase does not work alone to affect apoptosis of can-
cer cells. They need complex mechanism to affect apop-
tosis. Therefore, caspase-8 or caspase-9 inhibitor alone
did not strongly affect apoptosis of AGS gastric cancer
cells. PSE seems to trigger complex cascade of caspases
action to induce apoptosis. In contrast, the
mitochondrial-dependent apoptosis pathway was not
activated in AGS cells treated with the PSE extract.
Overexpression of Bcl-2, an anti-apoptotic protein, pre-
vents cells from initiating apoptosis, while increase of
Bax, a pro-apoptotic protein, induces the intrinsicFigure 8 PSE induces p53-dependent and Fas-mediated apoptosis inapoptosis pathway [32]. In the present study, we found
that the levels of Bax and Bcl-2 were not changed by the
PSE extract. The ratio of Bcl-2/Bax was also unchanged.
Furthermore, the PSE extract did not affect mitochon-
drial membrane potential (MMP), as shown by the
maintenance of red fluorescence when the cells were
dyed with JC-1. The mitochondrial membrane potential
of intact cells could be measured by JC-1, a membrane
potential sensitive dye [4]. When the MMP is stable, JC-
1 shows red fluorescence, due to the increase of J-
aggregate formation. With a loss of MMP, the formation
of J-aggregates is reduced, leading to a change from red
fluorescence to green fluorescence [30,33]. The lack of
change in caspase-9, Bcl-2 and Bax expression that we
observed is highly correlated with a stable MMP.
We also describe here that the PSE extract inhibited the
proliferation of AGS cells in a p53- and MDM2-
dependent manner. After DNA damage, p53 is phos-
phorylated, which can restrict aberrant cell growth or in-
duce apoptosis [34,35]. Phosphorylation of p53 leads to
reduced phosphorylation of MDM2, the negative regulator
of p53. MDM2 inactivation is known to be responsible for
p53 stabilization (MDM2-p53 pathway) [36,37]. The p53
tumor suppressor inhibits cellular proliferation by indu-
cing apoptosis in response to cellular stresses, includingAGS gastric cancer cells.
Choi et al. Journal of Biomedical Science 2012, 19:82 Page 11 of 12
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oncogene activation [38,39]. p53-dependent apoptosis is
induced by the caspase proteases and death receptors
[40,41] and functions through pro-apoptotic proteins in-
cluding Bax, Noxa, or PUMA [37].
Conclusions
In conclusion, this study demonstrated that the PSE ex-
tract on AGS cells significantly inhibits cell proliferation
and induces apoptotic cell death via the extrinsic Fas-
mediated apoptosis pathway (Figure 8). This induction
of apoptosis also leads to the activation of caspases such
as caspase-8, caspase-3, and cleavage of PARP. The p53-
MDM2 pathway also plays a role in the apoptotic cell
death of AGS cells that is induced by the PSE extract.
Our data clearly demonstrate that the PSE extract might
be a potential anticancer agent for gastric cancer.
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